Details for New Drug Application (NDA): 216445
✉ Email this page to a colleague
The generic ingredient in DAPTOMYCIN is daptomycin. There are ten drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for 216445
Tradename: | DAPTOMYCIN |
Applicant: | Aspiro |
Ingredient: | daptomycin |
Patents: | 0 |
Suppliers and Packaging for NDA: 216445
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 216445 | ANDA | Camber Pharmaceuticals, Inc. | 31722-215 | 31722-215-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-215-01) / 7 mL in 1 VIAL, SINGLE-DOSE |
DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 216445 | ANDA | Camber Pharmaceuticals, Inc. | 31722-215 | 31722-215-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-215-10) / 7 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 350MG/VIAL | ||||
Approval Date: | Dec 23, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription